News Sentiment

SYNACT sentiment intelligence

SynAct Pharma AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 20 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 21.80 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

88/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+15.2% over one week, +50.3% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

SynAct's resomelagon shows promising results in osteoarthritis

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 88/100 classification
One-week reaction 15.2% Price confirming higher
Trend fit Trend inactive 50.3% over four weeks
Fair value 20.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 18
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Biostock 18
simplywall.st 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 4

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20